Abemaciclib Dose Escalation in Early High-Risk Breast Cancer Adjuvant Therapy
Clinical trial NCT07599137 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07599137
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2027-12-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.